Home › Kidney Cancer (Renal Cell Carcinoma) › Arizona › Gilbert
Kidney Cancer (Renal Cell Carcinoma) clinical trials in Gilbert, AZ
4 studies for Kidney Cancer (Renal Cell Carcinoma) are looking for participants at sites in and around Gilbert (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
RecruitingObservational study
- Banner Health, Gilbert
A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
RecruitingPhase 1/2
- Banner MD Anderson Cancer Center, Gilbert
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
RecruitingPhase 1/2
- Banner MD Anderson Cancer Center, Gilbert
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
RecruitingPhase 3
- Banner MD Anderson Cancer Center, Gilbert
Kidney Cancer (Renal Cell Carcinoma) trials in other cities
- Houston, TX35 studies
- New York City, NY27 studies
- Nashville, TN23 studies
- Dallas, TX23 studies
- St. Louis, MO23 studies
- Los Angeles, CA20 studies
- Boston, MA16 studies
- Baldwin Park, CA16 studies
- Philadelphia, PA15 studies
- Pittsburgh, PA15 studies
- Queens, NY15 studies
- Rochester, MN14 studies
Other studies in Gilbert
- Non-Small Cell Lung Cancer13 studies
- Breast Cancer10 studies
- Colorectal Cancer9 studies
- Cancer (all types)8 studies
- Lung Cancer8 studies
- Bladder Cancer6 studies
- Heart Failure6 studies
- Multiple Myeloma6 studies
- Head and Neck Squamous Cell Carcinoma6 studies
- Cardiovascular Disease6 studies
- Metastatic Cancer6 studies
- Diffuse Large B-Cell Lymphoma5 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.